Gene · 7049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
981 to 1,000 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dentate gyrus activin signaling mediates the antidepressant response. | Transl Psychiatry | 2021 | 33414389 | PubTator, text mining | PubMed |
| Targeting TGFβ signal transduction for cancer therapy. | Signal Transduct Target Ther | 2021 | 33414388 | PubTator, text mining | PubMed |
| Bleomycin induces fibrotic transformation of bone marrow stromal cells to treat height loss of intervertebral disc through the TGFβR1/Smad2/3 pathway. | Stem Cell Res Ther | 2021 | 33413668 | PubTator, text mining | PubMed |
| Up-regulation of TβRIII facilitates the osteogenesis of supraspinous ligament-derived fibroblasts from patients with ankylosing spondylitis. | J Cell Mol Med | 2021 | 33410269 | PubTator, text mining | PubMed |
| Potential therapeutic approaches of microRNAs for COVID-19: Challenges and opportunities. | J Oral Biol Craniofac Res | 2021 | 33398242 | PubTator, text mining | PubMed |
| TGF-β1 increases permeability of ciliated airway epithelia via redistribution of claudin 3 from tight junction into cell nuclei. | Pflugers Arch | 2021 | 33386991 | PubTator, text mining | PubMed |
| Knockdown of long non‑coding RNA ANRIL inhibits the proliferation and promotes the apoptosis of Burkitt lymphoma cells through the TGF‑β1 signaling pathway. | Mol Med Rep | 2021 | 33325535 | PubTator, text mining | PubMed |
| Superficial CD34-positive Fibroblastic Tumour: Unique Subungual Presentation with Confounding Clinical Findings Resembling Fibrokeratoma-like Bowen's Disease. | Acta Derm Venereol | 2021 | 33320273 | PubTator, text mining | PubMed |
| Regulation of H2S-induced necroptosis and inflammation in broiler bursa of Fabricius by the miR-15b-5p/TGFBR3 axis and the involvement of oxidative stress in this process. | J Hazard Mater | 2021 | 33307448 | PubTator, text mining | PubMed |
| Gene coexpression networks reveal novel molecular endotypes in alpha-1 antitrypsin deficiency. | Thorax | 2021 | 33303696 | PubTator, text mining | PubMed |
| HELLS, a chromatin remodeler is highly expressed in pancreatic cancer and downregulation of it impairs tumor growth and sensitizes to cisplatin by reexpressing the tumor suppressor TGFBR3. | Cancer Med | 2021 | 33280236 | PubTator, text mining | PubMed |
| Survival prediction and response to immune checkpoint inhibitors: A prognostic immune signature for hepatocellular carcinoma. | Transl Oncol | 2021 | 33246289 | PubTator, text mining | PubMed |
| Role of TGF-β1-mediated epithelial-mesenchymal transition in the pathogenesis of tympanosclerosis. | Exp Ther Med | 2021 | 33235615 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Extracellular vesicles and oncogenic signaling. | Mol Oncol | 2021 | 33207034 | PubTator, text mining | PubMed |
| Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways. | J Cancer Res Clin Oncol | 2021 | 33205348 | PubTator, text mining | PubMed |
| Mutational drivers of cancer cell migration and invasion. | Br J Cancer | 2021 | 33204027 | PubTator, text mining | PubMed |
| ALK-1 to ALK-5 ratio dictated by the Akt1-β-catenin pathway regulates TGFβ-induced endothelial-to-mesenchymal transition. | Gene | 2021 | 33157202 | PubTator, text mining | PubMed |
| Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. | Biochim Biophys Acta Rev Cancer | 2021 | 33157161 | PubTator, text mining | PubMed |
| Application of quantitative transcriptomics in evaluating the ex vivo effects of per- and polyfluoroalkyl substances on Atlantic cod (Gadus morhua) ovarian physiology. | Sci Total Environ | 2021 | 33138996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7049/papers?page=50